Comparison between cells and cancer stem-like cells isolated from glioblastoma and astrocytoma on expression of anti-apoptotic and multidrug resistance-associated protein genes

Neuroscience

Volumn 154, Issue 2, 2008, Pages 541-550

  Jin, F ^a   Zhao, L ^a   Zhao, H Y ^a   Guo, S G ^b   Feng, J ^a   Jiang, X B ^a   Zhang, S L ^a   Wei, Y J ^a   Fu, R ^a   Zhao, J S ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

astrocytoma; cancer stem like cell; glioblastoma; glioma; livin; multidrug resistance associated protein

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 3; PROTEIN LIVIN;

ARTICLE; ASTROCYTOMA; CANCER STEM CELL; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; UPREGULATION;

ANTIGENS, CD; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; ASTROCYTOMA; BRAIN NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; FLUORESCENT ANTIBODY TECHNIQUE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOBLASTOMA; GLYCOPROTEINS; HUMANS; INDICATORS AND REAGENTS; INTERMEDIATE FILAMENT PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASTIC STEM CELLS; NERVE TISSUE PROTEINS; PEPTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUBULIN;

EID: 46549084099     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.03.054     Document Type: Article

References (33)

1. Akhyani N., Fotheringham J., Yao K., Rashti F., and Jacobson S. Efficacy of antiviral compounds in human herpesvirus-6-infected glial cells. J Neurovirol 12 (2006) 284-293
2. Andersson U., Malmer B., Bergenheim A.T., Brännström T., and Henriksson R. Heterogeneity in the expression of markers for drug resistance in brain tumors. Clin Neuropathol 23 (2004) 21-27
3. Aronica E., Gorter J.A., Jansen G.H., van Veelen C.W., van Rijen P.C., Leenstra S., Ramkema M., Scheffer G.L., Scheper R.J., and Troost D. Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: focal cortical dysplasia and glioneuronal tumors. Neuroscience 118 (2003) 417-429
4. Bansal K., Liang M.L., and Rutka J.T. Molecular biology of human gliomas. Technol Cancer Res Treat 5 (2006) 185-194
5. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., Dewhirst M.W., Bigner D.D., and Rich J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444 (2006) 756-760
6. Benyahia B., Huguet S., Declèves X., Mokhtari K., Crinière E., Bernaudin J.F., Scherrmann J.M., and Delattre J.Y. Multidrug resistance-associated protein MRP1 expression in human gliomas: chemosensitization to vincristine and etoposide by indomethacin in human glioma cell lines overexpressing MRP1. J Neurooncol 66 (2004) 65-70
7. Bocchini V., Casalone R., Collini P., Rebel G., and Lo Curto F. Changes in glial fibrillary acidic protein and karyotype during culturing of two cell lines established from human glioblastoma multiforme. Cell Tissue Res 265 (1991) 73-81
8. Bronger H., König J., Kopplow K., Steiner H.H., Ahmadi R., Herold-Mende C., Keppler D., and Nies A.T. ABCC drug efflux pumps and organic anion uptake transporters in human gliomas and the blood-tumor barrier. Cancer Res 65 (2005) 11419-11428
9. Calatozzolo C., Gelati M., Ciusani E., Sciacca F.L., Pollo B., Cajola L., Marras C., Silvani A., Vitellaro-Zuccarello L., Croci D., Boiardi A., and Salmaggi A. Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma. J Neurooncol 74 (2005) 113-121
10. Chang H., and Schimmer A.D. Livin/melanoma inhibitor of apoptosis protein as a potential therapeutic target for the treatment of malignancy. Mol Cancer Ther 6 (2007) 24-30
11. Duffy M.J., O'Donovan N., Brennan D.J., Gallagher W.M., and Ryan B.M. Survivin: a promising tumor biomarker. Cancer Lett 249 (2007) 49-60
12. Fukuda S., and Pelus L.M. Survivin, a cancer target with an emerging role in normal adult tissues. Mol Cancer Ther 5 (2006) 1087-1098
13. Ghods A.J., Irvin D., Liu G., Yuan X., Abdulkadir I.R., Tunici P., Konda B., Wachsmann-Hogiu S., Black K.L., and Yu J.S. Spheres isolated from 9L gliosarcoma rat cell line possess chemoresistant and aggressive cancer stem-like cells. Stem Cells 25 (2007) 1645-1653
14. Haga S., Hinoshita E., Ikezaki K., Fukui M., Scheffer G.L., Uchiumi T., and Kuwano M. Involvement of the multidrug resistance protein 3 in drug sensitivity and its expression in human glioma. Jpn J Cancer Res 92 (2001) 211-219
15. Hoffman R.M. The potential of nestin-expressing hair follicle stem cells in regenerative medicine. Expert Opin Biol Ther 7 (2007) 289-291
16. Homolya L., Váradi A., and Sarkadi B. Multidrug resistance-associated proteins: Export pumps for conjugates with glutathione, glucuronate or sulfate. Biofactors 17 (2003) 103-114
17. Huang R.C., Chang C.C., and Mold D. Survivin-dependent and -independent pathways and the induction of cancer cell death by tetra-O-methyl nordihydroguaiaretic acid. Semin Oncol 33 (2006) 479-485
18. Hwang H.S., Cho N.H., Maeng Y.S., Kang M.H., Park Y.W., and Kim Y.H. Differential expression of nestin in normal and pre-eclamptic human placentas. Acta Obstet Gynecol Scand 86 (2007) 909-914
19. Jin F., Zhao L., Zhao H.Y., Guo S.G., Feng J., Jiang X.B., Zhang S.L., Wei Y.J., Fu R., and Zhao J.S. Paradoxical expression of anti-apoptotic and MRP genes on cancer stem-like cell isolated from TJ905 glioblastoma multiforme cell line. Cancer Investigation (2008) [Epub ahead of print]. Doi: 10.1080/07357900701788064
20. Kempkensteffen C., Hinz S., Christoph F., Krause H., Koellermann J., Magheli A., Schrader M., Schostak M., Miller K., and Weikert S. Expression of the apoptosis inhibitor livin in renal cell carcinomas: correlations with pathology and outcome. Tumour Biol 28 (2007) 132-138
21. Liu B., Han M., Wen J.K., and Wang L. Livin/ML-IAP as a new target for cancer treatment. Cancer Lett 250 (2007) 168-176
22. Liu G., Yuan X., Zeng Z., Tunici P., Ng H., Abdulkadir I.R., Lu L., Irvin D., Black K.L., and Yu J.S. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 5 (2006) 67
23. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25 (2001) 402-408
24. Mohri M., Nitta H., and Yamashita J. Expression of multidrug resistance-associated protein (MRP) in human gliomas. J Neurooncol 49 (2000) 105-115
25. Nakada M., Nakada S., Demuth T., Tran N.L., Hoelzinger D.B., and Berens M.E. Molecular targets of glioma invasion. Cell Mol Life Sci 64 (2007) 458-478
26. Norden A.D., and Wen P.Y. Glioma therapy in adults. Neurologist 12 (2006) 279-292
27. Salmaggi A., Boiardi A., Gelati M., Russo A., Calatozzolo C., Ciusani E., Sciacca F.L., Ottolina A., Parati E.A., La Porta C., Alessandri G., Marras C., Croci D., and De Rossi M. Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype. Glia 54 (2006) 850-860
28. Sathornsumetee S., Reardon D.A., Desjardins A., Quinn J.A., Vredenburgh J.J., and Rich J.N. Molecularly targeted therapy for malignant glioma. Cancer 110 (2007) 13-24
29. Schulenburg A., Ulrich-Pur H., Thurnher D., Erovic B., Florian S., Sperr W.R., Kalhs P., Marian B., Wrba F., Zielinski C.C., and Valent P. Neoplastic stem cells: a novel therapeutic target in clinical oncology. Cancer 107 (2006) 2512-2520
30. Singh S.K., Clarke I.D., Hide T., and Dirks P.B. Cancer stem cells in nervous system tumors. Oncogene 23 (2004) 7267-7273
31. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., and Dirks P.B. Identification of human brain tumour initiating cells. Nature 432 (2004) 396-401
32. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., and Dirks P.B. Identification of a cancer stem cell in human brain tumors. Cancer Res 63 (2003) 5821-5828
33. Zaman G.J., Flens M.J., van Leusden M.R., de Haas M., Mülder H.S., Lankelma J., Pinedo H.M., Scheper R.J., Baas F., Broxterman H.J., and Borst P. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci U S A 91 (1994) 8822-8826